Personal CFO Solutions’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,306	Closed	-$302K	–	521
2025 Q4	$302K	Sell	11,306 -8	-0.1%	-$191	0.05%	367
2025 Q3	$241K	Buy	11,314 +165	+1%	+$3.9K	0.04%	434
2025 Q2	$240K	Sell	11,149 -1,003	-8%	-$18.6K	0.04%	404
2025 Q1	$202K	Sell	12,152 -78	-0.6%	-$1.42K	0.04%	428
2024 Q4	$224K	Buy	+12,230	New	+$197K	0.04%	412
2024 Q3	–	Sell	-12,614	Closed	-$205K	–	562
2024 Q2	$205K	Sell	12,614 -177	-1%	-$2.86K	0.03%	506
2024 Q1	$237K	Sell	12,791 -37	-0.3%	-$917	0.04%	472
2023 Q4	$402K	Buy	12,828 +20	+0.2%	+$478	0.07%	288
2023 Q3	$267K	Buy	12,808 +27	+0.2%	+$733	0.05%	351
2023 Q2	$306K	Sell	12,781 -79	-0.6%	-$1.76K	0.06%	324
2023 Q1	$242K	Buy	12,860 +14	+0.1%	+$267	0.05%	380
2022 Q4	$205K	Sell	12,846 -3,500	-21%	-$54.7K	0.04%	419
2022 Q3	$267K	Hold	16,346	–	–	0.07%	277
2022 Q2	$230K	Buy	16,346 +500	+3%	+$9.33K	0.05%	345
2022 Q1	$384K	Buy	15,846 +1,000	+7%	+$24.2K	0.08%	248
2021 Q4	$347K	Sell	14,846 -13,154	-47%	-$265K	0.07%	280
2021 Q3	$465K	Buy	28,000 +2,800	+11%	+$54K	0.1%	200
2021 Q2	$615K	Hold	25,200	–	–	0.13%	159
2021 Q1	$650K	Buy	25,200 +3,400	+16%	+$150K	0.14%	133
2020 Q4	$1.17M	Hold	21,800	–	–	0.29%	78
2020 Q3	$1K	Buy	21,800 +1,000	+5%	+$43.2K	0.33%	51
2020 Q2	$1.01M	Buy	20,800 +3,100	+18%	+$149K	0.3%	76
2020 Q1	$748K	Buy	17,700 +8,100	+84%	+$334K	0.27%	83
2019 Q4	$411K	Buy	+9,600	New	+$418K	0.12%	166